Staar Surgical Co financials
$22.43+7.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Jan 2 | FY24 Dec 27 | FY23 Dec 29 | FY22 Dec 30 | FY21 Dec 31 | FY20 Jan 1 | FY19 Jan 3 | FY18 Dec 28 | FY17 Dec 29 | FY16 Dec 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.4M | $313.9M | $322.4M | $284.4M | $230.5M | $163.5M | $150.2M | $124.0M | $90.6M | $82.4M |
| Gross profit | $182.4M | $239.6M | $252.7M | $223.4M | $178.6M | $118.4M | $112.0M | $91.5M | $64.3M | $58.4M |
| Gross margin | 76.2% | 76.3% | 78.4% | 78.5% | 77.5% | 72.4% | 74.5% | 73.8% | 70.9% | 70.8% |
| Operating income | -$91.7M | -$12.6M | $28.1M | $43.8M | $33.3M | $6.8M | $11.9M | $6.6M | -$3.6M | -$12.7M |
| Net income | -$80.4M | -$20.2M | $21.3M | $39.7M | $27.5M | $5.9M | $14.0M | $5.0M | -$2.1M | -$12.1M |
| Net margin | −33.6% | −6.4% | 6.6% | 13.9% | 11.9% | 3.6% | 9.4% | 4.0% | −2.4% | −14.7% |
| Diluted EPS | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 |
| EBITDA | -$54.4M | -$5.7M | $33.2M | $48.3M | $37.0M | $9.9M | $15.6M | $9.1M | -$277.0K | -$9.8M |
| Operating cash flow | -$34.2M | $15.7M | $14.6M | $35.7M | $44.0M | $21.0M | $25.8M | $12.8M | $2.9M | $1.0M |
| Free cash flow | -$40.0M | -$7.7M | -$3.6M | $17.6M | $30.3M | $12.5M | $15.7M | $10.5M | $1.8M | -$2.2M |
| Diluted shares | 49.6M | 49.1M | 49.4M | 49.4M | 49.5M | 48.0M | 46.9M | 45.3M | 41.0M | 40.3M |
Balance sheet
| Period end | Jan 2 | Dec 27 | Dec 29 | Dec 30 | Dec 31 | Jan 1 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $153.2M | $144.2M | $183.0M | $86.5M | $199.7M | $152.5M |
| Short-term investments | $34.4M | $86.3M | $37.7M | $125.2M | — | — |
| Total debt | $0.00 | $42.0K | $207.0K | $379.0K | $509.0K | $1.8M |
| Total assets | $451.7M | $509.5M | $488.7M | $418.8M | $345.8M | $257.4M |
| Total liabilities | $107.5M | $112.2M | $102.7M | $82.7M | $87.2M | $60.2M |
| Shareholders' equity | $344.2M | $397.3M | $386.0M | $336.1M | $258.6M | $197.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology